Safety and Tolerability of Antioxidant (AT-001)for Reducing Brain Oxidative Stress

NCT01731093 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Oxidative Stress

Interventions

DRUG: AT-001
DRUG: Placebo

Sponsor

Alltech Life Sciences Inc.